References

  1. Adnan Alatoom, Jennie Duval V, Dominick Cavuoti. Fatal Endocarditis Caused by Arcanobacterium haemolyticum: Case Report and Review of the Literature. Clinical Microbiology Newsletter. January 15, 2012;34(2):13-17. PubMed | Google Scholar

  2. Regina Linder. Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection. An Med Interna. 2002 Sep; 19(9):473-6. PubMed | Google Scholar

  3. Karolina Hedman, Annelie Brauner. Septicaemia caused by Arcanobacterium haemolyticum smooth type in an immunocompetent patient. Journal of Medical Microbiology. 2012;61:328-1329. Google Scholar

  4. Puerto Alonso JL, García-Martos P, Girón González JA. Infections by Arcanobacterium haemolyticum: an emerging pathogen. Surg Infect. 2013 Jun;14(3):322-4. PubMed | Google Scholar

  5. Jost BH, Lucas EA, Billington SJ, Ratner AJ, McGee DJ. Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum. J Infect Dis. 1997 Jun;175(6):1515-8. PubMed | Google Scholar

  6. Fernández-Suárez A, Benítez JM, Vidal AM, Iglesias JM. Lemierre's syndrome and septicaemia caused solely by Arcanobacterium haemolyticum in a young immunocompetent patient. J Med Microbiol. 2009 Dec;58(Pt 12):1645-8. PubMed | Google Scholar

  7. Mackenzie A, Fuite LA, Chan FT, King J, Allen U, MacDonald N, Diaz-Mitoma F. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis. 1995 Jul; 21(1):177-81. PubMed | Google Scholar

  8. Sammra O, Friis-Moller A, Balbutskaya A, Hijazin M, Nagib S, Alber J, Lämmler C, Abdulmawjood A, Timke M, Kostrzewa M, Prenger-Berninghoff E. Phenotypic and genotypic characteristics of Arcanobacterium haemolyticum isolated from clinical samples in a Danish hospital. MC Microbiol. 2011 Oct 26;11:239. PubMed | Google Scholar

  9. Jordi Vila, Pedro Juiz, Carlos Salas, Manel Almela, Celia García de la Fuente,Yuliya Zboromyrska, Jesús Navas, Jordi Bosch, Jesús Agüero,Jorge Puig de la Bellacasa and Luis Martínez-Martínez. Identification of Clinically Relevant Corynebacterium spp, Arcanobacterium haemolyticum, and Rhodococcus equi by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol. May 2012;50(5):1745-1747. PubMed | Google Scholar

  10. Carlson P, Kontiainen S, Renkonen OV. Antimicrobial susceptibility of Arcanobacterium haemolyticum. Antimicrob Agents Chemother. Jan 1994;38(1):142-143. PubMed | Google Scholar